SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists
- PMID: 33765218
- DOI: 10.1007/s00259-021-05316-0
SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists
References
-
- Giovanella L, Ruggeri RM, Ovčariček PP, Campenni A, Treglia G, Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. 2021;1–8. https://doi.org/10.1007/s40336-021-00419-y .
-
- Slatosky J, Shipton B, Wahba H. Thyroiditis: differential diagnosis and management. Am Fam Physician. 2000;61:1047–52. - PubMed
-
- Desailloud R, Hober D, Desailloud R. Viruses and thyroiditis: an update. Virol J. 2009;6:5. https://doi.org/10.1186/1743-422X-6-5 . - DOI - PubMed - PMC
-
- Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80. - DOI
-
- Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Investig. 2020;6:1–6. https://doi.org/10.1007/s40618-020-01436-w . - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
